![Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease | Gut Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease | Gut](https://gut.bmj.com/content/gutjnl/48/2/186/F1.large.jpg)
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease | Gut
![PDF] Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. | Semantic Scholar PDF] Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/edf56986bab79b121265bb81c272bc5d123e15c4/3-Table1-1.png)
PDF] Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. | Semantic Scholar
Muwanguzi Moses on X: "RT @drkeithsiau: Steroid conversion chart 🔁 #4KMedEd https://t.co/Qon5A7tVmV" / X
![Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources | Semantic Scholar Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3101bfd9623e6639c72fe39afc806a9d4c9b4164/4-Table1-1.png)
Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources | Semantic Scholar
![Utilization of Quality by Design, Kinetic Modeling, and Computational Fluid Dynamics for Process Optimization and Scale-Up,Organic Process Research & Development - X-MOL Utilization of Quality by Design, Kinetic Modeling, and Computational Fluid Dynamics for Process Optimization and Scale-Up,Organic Process Research & Development - X-MOL](https://xpic.x-mol.com/20230521%2F10.1021_acs.oprd.3c00015.jpg)
Utilization of Quality by Design, Kinetic Modeling, and Computational Fluid Dynamics for Process Optimization and Scale-Up,Organic Process Research & Development - X-MOL
![Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19 | medRxiv Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19 | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/07/28/2021.06.01.21258147/F1/graphic-3.large.jpg)